Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View | Barron's
Israel stocks fall for fifth day; Teva rises - MarketWatch
Israel stocks rise as investors key on Teva, ICL - MarketWatch
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Teva Pharmaceuticals stock falls 11% after earnings miss - MarketWatch
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Teva Pharmaeutical Stock Gets Upgrade From Analyst | Barron's
Teva Pharmaceuticals - Wikipedia
TEVA — TradingView
Israel stocks tick lower; Teva, Itamar in focus - MarketWatch
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
TEVA — TradingView
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Israel stocks at record; Biogen remarks cost Teva - MarketWatch
Deckers racked up $2 billion in Ugg boots sales in record year; stock jumps 14% - MarketWatch
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Three health-care deals today are paying huge premiums - MarketWatch
Teva stock drops on guidance, manufacturing problems - MarketWatch
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Perrigo rejects Mylan, opening door for Teva - MarketWatch
Market News
Teva earnings preview: Opioid suits are 'key' - MarketWatch
